BacLite Rapid MRSA Clinical Performance

Stopped early

Conditions studied: Methicillin Resistance

In brief

The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.

Key facts

Study ID

NCT00541632

Run by

Solventum US LLC

Starts

2007-10-01

Expected to finish

2008-03-01

Last updated by the study team

2024-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects 18 years or older
• Subjects willing to document demographic characteristics
• Subjects willing to have their nose swabbed
• Subjects (or legal representative) willing to sign consent and authorization forms

You may not qualify if…

• Subjects who use Vicks Sinex Nasal spray or other nasal sprays
• Subjects with prescribed nasal medical devices where collecting samples may resent more than minimal risk to subjects
• Subjects having nasal prosthetics, jewelry or trauma to the nose or anything that may prevents sampling the anterior nares
• Investigator believes that subject is unsuitable for inclusion.

Where it is running

• Denver Health Medical Center — Denver, Colorado, United States
• Atlanta Institute for Medical Research, Inc. — Atlanta, Georgia, United States
• Evanston Northwestern Healthcare — Evanston, Illinois, United States
• University of Iowa — Iowa City, Iowa, United States
• University of Maryland — Baltimore, Maryland, United States
• Wayne State University — Detroit, Michigan, United States
• Washington University — St Louis, Missouri, United States
• Wake Forest University — Winston-Salem, North Carolina, United States
• Cleveland Clinic — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.